The Legal Intelligencer | Commentary
By Jenna Loadman and Tyler Marandola | March 30, 2018
In the heyday of the video-sharing service Vine, Kayla Newman, a Chicago-area teen, birthed a new catchphrase for the millennial generation with two words—“on fleek.”
By Michael F. Snyder and Anthony S. Volpe | March 30, 2018
This article advocates for having in-house or retained counsel make periodic reviews of corporate employment agreements and for having counsel involved in any new hire where there is strong likelihood that the position will lead to the creation of IP.
The Legal Intelligencer | Commentary
By W. Drew Kastner, Stephenie Wingyuen Yeung, Andrew Chou and Sekou Lewis | March 30, 2018
Intellectual property rights in trademarks, copyrights, domain names and website content are among a company's most significant assets and account for key elements of a business' core operations and consumer brand recognition.
Delaware Business Court Insider | News
By Tom McParland | March 29, 2018
A Delaware federal judge on Wednesday wiped out a $235 million verdict against Teva Pharmaceuticals for supposedly infringing a GlaxoSmithKline plc patent for the hypertension drug Coreg.
The Legal Intelligencer | Commentary
By Richard A. Catalina Jr. | March 29, 2018
Decentralized data structure management technology (DDSM), such as blockchain and distributed ledger technology, is grabbing ever-increasing attention as a result of its potential to revolutionize the way we conduct business, run our governments and go about daily life.
The Legal Intelligencer | Commentary
By Scott C. Oberlander | March 29, 2018
May 22, 2017, was a game-changing day for patent litigators across the United States, albeit a day that many experts assumed was coming.
By Scott Graham | March 28, 2018
The D.C.-based appellate court on Wednesday stopped a PTAB proceeding in which the board has declined to recognize the Saint Regis Mohawk Tribe's sovereign immunity.
Delaware Business Court Insider | News
By Tom McParland | March 28, 2018
Gilead Sciences Inc. on Tuesday sued to stop a rival drugmaker from bringing a generic version of Sovaldi to market, as the company continues its campaign to protect the hepatitis C treatment amid rapidly declining sales.
Daily Business Review | Commentary
By Samuel Lewis | March 28, 2018
After years of protracted litigation, including two jury trials and two appeals, Google and Oracle are now destined for yet another trial arising from Google's alleged unauthorized use of 37 of Oracle's Java application programming interfaces (APIs) in the Android smartphone operating system.
By Scott Graham | March 27, 2018
Will there be a third trial in Oracle v. Google? Or a Supreme Court showdown? And what's the Federal Circuit doing in the middle of a copyright case, anyway?
Presented by BigVoodoo
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS